Question 15 of 20 Intermediate Scenario
Should a medication error with no adverse reaction be submitted as an ICSR?
Short answer
Under EU GVP, no. Reports of overdose, abuse, misuse, medication error or occupational exposure without a suspected adverse reaction are recorded and considered in the PSUR, not submitted as ICSRs. If a reaction occurs, the report becomes a normal case and follows the standard timelines.
Why
GVP Module VI groups these as special situations. A pharmacist who reports that a patient was dispensed 10 mg instead of 1 mg but felt fine has given useful information, but there is no suspected reaction, so there is no valid ICSR. The holder records it, includes it in periodic analysis, and, if a pattern emerges that affects the benefit-risk balance, notifies authorities as a safety issue.
Patterns matter: repeated mix-ups between two strengths with similar packaging can justify a labeling or packaging change before anyone is harmed. If the same patient later develops symptoms, the report becomes a case and the clock starts. Pregnancy exposure is handled differently: GVP asks holders to follow up exposure reports to collect the pregnancy outcome and the child's development, even when no reaction was reported at first.
Lack of efficacy may also need submission in some settings, such as vaccines or life-threatening diseases. Local rules outside the EU can differ, so a global system must apply the strictest relevant rule.
A strong answer covers
- Special situations in GVP Module VI
- No suspected reaction means no ICSR
- Record and analyze in PSURs, notify patterns that affect benefit-risk
- Pregnancy exposure needs outcome follow-up
- Other regions may have different rules
Common mistakes
- Submitting every medication error as an expedited ICSR.
- Discarding error reports because no harm occurred.
- Closing a pregnancy exposure report without seeking the outcome.
The interviewer might ask next
What pattern in medication error reports would make you propose a packaging change?